{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:25:44Z","timestamp":1791980744898,"version":"4.4.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>In a rotenone-induced Parkinson\u2019s disease (PD) mouse model, our study explored the neuroprotective effect of febuxostat, a non-purine selective xanthine oxidase inhibitor approved for gout management. In addition, this study explored the role of PI3K\/Akt signaling and its downstream effectors in this neuroprotective activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Mice were administered rotenone (1.5\u00a0mg\/kg, s.c., every 48\u00a0h) for 3\u00a0weeks to induce PD. Mice were treated with febuxostat (5\u00a0mg\/kg, p.o.) daily 1\u00a0h before rotenone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>Febuxostat improved motor function in open field, rotarod, and grip strength tests, attenuated body weight loss, preserved dopaminergic neurons, and restored TH levels in the striatum and substantia nigra (SN), elevated PI3K, p-Akt, and p-mTOR, increased the expression of Nrf2, lowered the expression of p-GSK-3\u03b2 (Tyr216) and Bax\/Bcl2 ratio, replenished GSH and HO-1 levels, and reduced MDA, TNF-\u03b1, and NF-\u03baB levels in the striatum of rotenone-intoxicated mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study revealed that febuxostat provides neuroprotective benefits in a rotenone-induced PD model in mice. These beneficial effects are likely due to inhibition of oxidative stress, inflammation, and apoptosis. Additionally, the observed antioxidant, anti-inflammatory, and anti-apoptotic effects of febuxostat may be related to its ability to activate PI3K\/Akt\/mTOR cascade, diminish p-GSK-3\u03b2 expression, and up-regulate Nrf2\/HO-1 signaling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jpp\/rgag009","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T12:25:30Z","timestamp":1768911930000},"source":"Crossref","is-referenced-by-count":1,"title":["The protective effect of febuxostat in a rotenone mouse model of Parkinson\u2019s disease: the interplay between PI3K\/Akt\/mTOR, GSK-3\u03b2, and Nrf2\/HO-1 signaling pathways"],"prefix":"10.1093","volume":"78","author":[{"given":"Kholoud Mohamed","family":"Lasheen","sequence":"first","affiliation":[{"name":"School of Pharmacy, Newgiza University , Cairo\u2013Alexandria Desert Road, First 6th of October City, Giza 12563 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Mohammad","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Newgiza University , Cairo\u2013Alexandria Desert Road, First 6th of October City, Giza 12563 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouran","family":"Ahmed","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Newgiza University , Cairo\u2013Alexandria Desert Road, First 6th of October City, Giza 12563 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7597-2352","authenticated-orcid":false,"given":"Ayman El-Sayed","family":"El-Sahar","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University , Kasr Al-Ainy Street, El-Manial District, Cairo 11562 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5337-3658","authenticated-orcid":false,"given":"Rabab Hamed","family":"Sayed","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University , Kasr Al-Ainy Street, El-Manial District, Cairo 11562 ,","place":["Egypt"]},{"name":"Clinical Pharmacy Department, School of Pharmacy, Newgiza University , Cairo\u2013Alexandria Desert Road, First 6th of October City, Giza 12563 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"2026021412014481800_ref1","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/MDS.27063","article-title":"Projection of the prevalence of Parkinson\u2019s disease in the coming decades: revisited","volume":"33","author":"Rossi","year":"2018","journal-title":"Mov Disord"},{"key":"2026021412014481800_ref2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1196\/ANNALS.1332.015","article-title":"The degeneration of dopamine neurons in Parkinson\u2019s disease: insights from embryology and evolution of the mesostriatocortical system","volume":"1035","author":"Vernier","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"2026021412014481800_ref3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/J.TINS.2018.09.007","article-title":"Triggers, facilitators and aggravators: redefining Parkinson\u2019s disease pathogenesis","volume":"42","author":"Johnson","year":"2019","journal-title":"Trends Neurosci"},{"key":"2026021412014481800_ref4","doi-asserted-by":"publisher","first-page":"13830","DOI":"10.3390\/IJMS131113830","article-title":"Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR Cascade","volume":"13","author":"Maiese","year":"2012","journal-title":"Int J Mol Sci"},{"key":"2026021412014481800_ref5","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/J.CELLSIG.2014.08.019","article-title":"The role of PI3K\/AKT\/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration","volume":"26","author":"Heras-Sandoval","year":"2014","journal-title":"Cell Signal"},{"key":"2026021412014481800_ref6","doi-asserted-by":"publisher","first-page":"107900","DOI":"10.1016\/J.NEUROPHARM.2019.107900","article-title":"Neuroprotective effect of crocin against rotenone-induced Parkinson\u2019s disease in rats: interplay between PI3K\/Akt\/mTOR signaling pathway and enhanced expression of miRNA-7 and miRNA-221","volume":"164","author":"Salama","year":"2020","journal-title":"Neuropharmacology"},{"key":"2026021412014481800_ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S10787-023-01305-X","article-title":"PI3K\/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson\u2019s disease in rats","volume":"2023","author":"Farid","year":"2023","journal-title":"Inflammopharmacology"},{"key":"2026021412014481800_ref8","doi-asserted-by":"publisher","first-page":"104846","DOI":"10.1016\/J.YEXMP.2022.104846","article-title":"The PI3K-AKT pathway: a plausible therapeutic target in Parkinson\u2019s disease","volume":"129","author":"Goyal","year":"2023","journal-title":"Exp Mol Pathol"},{"key":"2026021412014481800_ref9","doi-asserted-by":"publisher","first-page":"111344","DOI":"10.1016\/J.ECOENV.2020.111344","article-title":"The protective effect of biochanin a against rotenone-induced neurotoxicity in mice involves enhancing of PI3K\/Akt\/mTOR signaling and beclin-1 production","volume":"205","author":"El-Sherbeeny","year":"2020","journal-title":"Ecotoxicol Environ Saf"},{"key":"2026021412014481800_ref10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/TOXSCI\/KFU211","article-title":"Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1\/eIF4E pathways, leading to neuronal apoptosis","volume":"143","author":"Zhou","year":"2015","journal-title":"Toxicol Sci"},{"key":"2026021412014481800_ref11","doi-asserted-by":"publisher","DOI":"10.1038\/SREP32206","article-title":"Sulforaphane protects against rotenone-induced neurotoxicity in vivo: involvement of the mTOR, Nrf2, and autophagy pathways","author":"Zhou","year":"2016","journal-title":"Sci Rep"},{"key":"2026021412014481800_ref12","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1007\/S11064-017-2184-1","article-title":"Intranasal administration of GDNF protects against neural apoptosis in a rat model of Parkinson\u2019s disease through PI3K\/Akt\/GSK3\u03b2 pathway","volume":"42","author":"Yue","year":"2017","journal-title":"Neurochem Res"},{"key":"2026021412014481800_ref13","doi-asserted-by":"publisher","first-page":"115496","DOI":"10.1016\/J.BCP.2023.115496","article-title":"GSK-3\u03b2: an exuberating neuroinflammatory mediator in Parkinson\u2019s disease","volume":"210","author":"Samim Khan","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"2026021412014481800_ref14","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1159\/000485580","article-title":"The key roles of GSK-3\u03b2 in regulating mitochondrial activity","volume":"44","author":"Yang","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"2026021412014481800_ref15","doi-asserted-by":"publisher","first-page":"154124","DOI":"10.1016\/J.PHYMED.2022.154124","article-title":"Lignans from Eucommia ulmoides Oliver leaves exhibit neuroprotective effects via activation of the PI3K\/Akt\/GSK-3\u03b2\/Nrf2 signaling pathways in H2O2-treated PC-12 cells","volume":"101","author":"Han","year":"2022","journal-title":"Phytomedicine"},{"key":"2026021412014481800_ref16","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/J.LFS.2004.10.031","article-title":"Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase\/xanthine dehydrogenase","volume":"76","author":"Takano","year":"2005","journal-title":"Life Sci"},{"key":"2026021412014481800_ref17","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/NAR\/GKX1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2026021412014481800_ref18","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s12640-020-00316-8","article-title":"Febuxostat inhibits MPP+-induced inflammatory response through inhibiting the JNK\/NF-\u03baB pathway in astrocytes","volume":"39","author":"Yan","year":"2021","journal-title":"Neurotox Res"},{"key":"2026021412014481800_ref19","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS22137183","article-title":"Effects of venlafaxine, risperidone and Febuxostat on Cuprizone-induced demyelination, Behavioral deficits and oxidative stress","volume":"22","author":"Mihai","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026021412014481800_ref20","doi-asserted-by":"publisher","first-page":"118070","DOI":"10.1016\/J.LFS.2020.118070","article-title":"The role of KATP channel blockade and activation in the protection against neurodegeneration in the rotenone model of Parkinson\u2019s disease","volume":"257","author":"Abdelkader","year":"2020","journal-title":"Life Sci"},{"key":"2026021412014481800_ref21","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","article-title":"The open-field test: a critical review","volume":"83","author":"Walsh","year":"1976","journal-title":"Psychol Bull"},{"key":"2026021412014481800_ref22","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jps.3030460322","article-title":"A note on a simple apparatus for detecting neurological deficit in rats and mice","volume":"46","author":"Dunham","year":"1957","journal-title":"J Am Pharm Assoc Am Pharm Assoc (Baltim)"},{"key":"2026021412014481800_ref23","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1073\/PNAS.92.12.5341","article-title":"Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein","volume":"92","author":"Moran","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026021412014481800_ref24","article-title":"Determinaci\u00f3n de prote\u00ednas: M\u00e9todo de Bradford","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"2026021412014481800_ref25","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2147\/JIR.S299927","article-title":"Microglial activation mediates noradrenergic locus Coeruleus neurodegeneration via complement receptor 3 in a rotenone-induced Parkinson\u2019s disease mouse model","volume":"14","author":"Jing","year":"2021","journal-title":"J Inflamm Res"},{"key":"2026021412014481800_ref26","doi-asserted-by":"publisher","first-page":"e14253","DOI":"10.1111\/JFBC.14253","article-title":"Ginkgo biloba protects striatal neurodegeneration and gut phagoinflammatory damage in rotenone-induced mice model of Parkinson\u2019s disease: role of executioner caspase-3\/Nrf2\/ARE signaling","volume":"46","author":"Adebayo","year":"2022","journal-title":"J Food Biochem"},{"key":"2026021412014481800_ref27","doi-asserted-by":"publisher","first-page":"109841","DOI":"10.1016\/J.CBI.2022.109841","article-title":"Modulation of histone deacetylase, the ubiquitin proteasome system, and autophagy underlies the neuroprotective effects of venlafaxine in a rotenone-induced Parkinson\u2019s disease model in rats","volume":"354","author":"El-Saiy","year":"2022","journal-title":"Chem Biol Interact"},{"key":"2026021412014481800_ref28","doi-asserted-by":"publisher","DOI":"10.3892\/MMR.2022.12607","article-title":"Comparison of the effect of rotenone and 1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine on inducing chronic Parkinson\u2019s disease in mouse models","volume":"25","author":"Zhang","year":"2022","journal-title":"Mol Med Rep"},{"key":"2026021412014481800_ref29","doi-asserted-by":"publisher","first-page":"121129","DOI":"10.1016\/J.LFS.2022.121129","article-title":"Xanthotoxin modulates oxidative stress, inflammation, and MAPK signaling in a rotenone-induced Parkinson\u2019s disease model","volume":"310","author":"Sayed","year":"2022","journal-title":"Life Sci"},{"key":"2026021412014481800_ref30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrm2882","article-title":"The emerging mechanisms of isoform-specific PI3K signalling","volume":"11","author":"Vanhaesebroeck","year":"2010","journal-title":"Nature Reviews Molecular Cell Biology 2010 11:5"},{"key":"2026021412014481800_ref31","doi-asserted-by":"publisher","first-page":"12:648636","DOI":"10.3389\/FPHAR.2021.648636\/FULL","article-title":"PI3K\/AKT signal pathway: a target of natural products in the prevention and treatment of Alzheimer\u2019s disease and Parkinson\u2019s disease","author":"Long","year":"2021","journal-title":"Front Pharmacol"},{"key":"2026021412014481800_ref32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/J.NEULET.2009.09.055","article-title":"Akt signal transduction dysfunction in Parkinson\u2019s disease","volume":"467","author":"Timmons","year":"2009","journal-title":"Neurosci Lett"},{"key":"2026021412014481800_ref33","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4062\/BIOMOLTHER.2014.026","article-title":"\u0392-Lapachone-induced apoptosis of human gastric carcinoma AGS cells is caspase-dependent and regulated by the PI3K\/Akt pathway","volume":"22","author":"Yu","year":"2014","journal-title":"Biomol Ther (Seoul)"},{"key":"2026021412014481800_ref34","doi-asserted-by":"publisher","first-page":"104553","DOI":"10.1016\/J.FITOTE.2020.104553","article-title":"Cannabidiol exerts protective effects in an in vitro model of Parkinson\u2019s disease activating AKT\/mTOR pathway","volume":"143","author":"Gugliandolo","year":"2020","journal-title":"Fitoterapia"},{"key":"2026021412014481800_ref35","doi-asserted-by":"publisher","first-page":"48872","DOI":"10.1074\/JBC.M305870200","article-title":"Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53","volume":"278","author":"Watcharasit","year":"2003","journal-title":"J Biol Chem"},{"key":"2026021412014481800_ref36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/J.PHRS.2015.03.010","article-title":"Glycogen synthase kinase-3 beta (GSK-3\u03b2) signaling: implications for Parkinson\u2019s disease","volume":"97","author":"Golpich","year":"2015","journal-title":"Pharmacol Res"},{"key":"2026021412014481800_ref37","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6571484","article-title":"Neuroprotective effect of Chlorogenic acid on mitochondrial dysfunction-mediated apoptotic death of DA neurons in a parkinsonian mouse model","volume":"2020","author":"Sen","year":"2020","journal-title":"Oxidative Med Cell Longev"},{"key":"2026021412014481800_ref38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/J.TOXLET.2014.11.029","article-title":"The molecular mechanism of rotenone-induced \u03b1-synuclein aggregation: emphasizing the role of the calcium\/GSK3\u03b2 pathway","volume":"233","author":"He","year":"2015","journal-title":"Toxicol Lett"},{"key":"2026021412014481800_ref39","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.3892\/MMR.2014.2080","article-title":"Association of glycogen synthase kinase-3\u03b2 with Parkinson\u2019s disease (review)","volume":"9","author":"Li","year":"2014","journal-title":"Mol Med Rep"},{"key":"2026021412014481800_ref40","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/629507","article-title":"GSK-3\u03b2 inhibition attenuates CLP-induced liver injury by reducing inflammation and hepatic cell apoptosis","volume":"2014","author":"Zhang","year":"2014","journal-title":"Mediat Inflamm"},{"key":"2026021412014481800_ref41","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.2174\/1568026620666200516153136","article-title":"Glycogen synthase kinase 3 (GSK3): its role and inhibitors","volume":"20","author":"Wadhwa","year":"2020","journal-title":"Curr Top Med Chem"},{"key":"2026021412014481800_ref42","doi-asserted-by":"publisher","first-page":"e13031","DOI":"10.1111\/ACEL.13031","article-title":"Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease","volume":"18","author":"Trist","year":"2019","journal-title":"Aging Cell"},{"key":"2026021412014481800_ref43","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/08923973.2024.2373216","article-title":"Reno-protective effect of fenofibrate and febuxostat against vancomycin-induced acute renal injury in rats: targeting PPAR\u03b3\/NF-\u03baB\/COX-II and AMPK\/Nrf2\/HO-1 signaling pathways","volume":"46","author":"El-Shoura","year":"2024","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"2026021412014481800_ref44","doi-asserted-by":"publisher","first-page":"3527579","DOI":"10.1155\/2016\/3527579","article-title":"Xanthine oxidoreductase-derived reactive species: physiological and pathological effects","volume":"2016","author":"Battelli","year":"2016","journal-title":"Oxidative Med Cell Longev"},{"key":"2026021412014481800_ref45","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3892\/ETM.2021.10029","article-title":"Dl-butylphthalide inhibits rotenone-induced oxidative stress in microglia via regulation of the Keap1\/Nrf2\/HO-1 signaling pathway","volume":"21","author":"Luo","year":"2021","journal-title":"Exp Ther Med"},{"key":"2026021412014481800_ref46","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/J.ATHEROSCLEROSIS.2014.10.006","article-title":"Xanthine oxidoreductase in atherosclerosis pathogenesis: not only oxidative stress","volume":"237","author":"Battelli","year":"2014","journal-title":"Atherosclerosis"},{"key":"2026021412014481800_ref47","doi-asserted-by":"publisher","first-page":"118307","DOI":"10.1016\/J.LFS.2020.118307","article-title":"Febuxostat mitigates concanavalin A-induced acute liver injury via modulation of MCP-1, IL-1\u03b2, TNF-\u03b1, neutrophil infiltration, and apoptosis in mice","volume":"260","author":"Maresh","year":"2020","journal-title":"Life Sci"},{"key":"2026021412014481800_ref48","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1080\/01480545.2021.1977315","article-title":"Febuxostat, an inhibitor of xanthine oxidase, ameliorates ionizing radiation-induced lung injury by suppressing caspase-3, oxidative stress and NF-\u03baB","volume":"45","author":"Raeispour","year":"2022","journal-title":"Drug Chem Toxicol"},{"key":"2026021412014481800_ref49","doi-asserted-by":"publisher","first-page":"740","DOI":"10.22038\/IJBMS.2024.74655.16212","article-title":"Febuxostat attenuates secondary brain injury caused by cerebral hemorrhage through inhibiting inflammatory pathways","volume":"27","author":"Bai","year":"2024","journal-title":"Iran J Basic Med Sci"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/78\/2\/rgag009\/66902236\/rgag009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/78\/2\/rgag009\/66902236\/rgag009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T17:01:53Z","timestamp":1771088513000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/doi\/10.1093\/jpp\/rgag009\/8483958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgag009","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,2]]},"article-number":"rgag009"}}